Fej-nyaki daganatok: vizsgálatok itt: Németország
51 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 15.. Ask the study team whether a trial fits you.
- No phaseTaking peopleHead and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome
- Where
- Essen, Hanover
- Életkor
- 18 év and over
- People
- 200
- Run by
- AIO-Studien-gGmbH
See details and how to joinNCT06380686 - 3. fázisTaking peopleJNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
- Where
- Giessen, Hanover, Jena, München, Rostock
- Életkor
- 60 év and over
- People
- 500 worldwide
- Run by
- Johnson & Johnson Enterprise Innovation Inc.
See details and how to joinNCT04892173 · EU 2024-520386-31-00 - 1/2. fázisTaking peopleA Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
- Where
- Essen, Leipzig, Stuttgart
- Életkor
- 18 év and over
- People
- 287 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06385080 · EU 2023-508418-40-00 - 3. fázisTaking peopleA Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
- Where
- Bonn, Essen, Frankfurt Am Main, Giessen, Hanover, Leipzig, Regensburg, Rostock, Ulm
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07276399 · EU 2025-521917-24-00 - 2/3. fázisTaking peopleFORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
- Where
- Aachen, Berlin, Brunswick, Chemnitz, Dresden, Duesseldorf, Essen, Goettingen, Hanover, Karlsruhe, Mainz, Munich, Stuttgart, Ulm
- Életkor
- 18 év and over
- People
- 650 worldwide
- Run by
- Bicara Therapeutics
See details and how to joinNCT06788990 · EU 2024-519654-37-00 - 2. fázisNot yet taking people in NémetországDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- Where
- Frankfurt am Main, Giessen
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00 - 3. fázisTaking peopleA Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in Patients With Head and Neck Cancer.
- Where
- Cologne, Frankfurt Am Main, Freiburg im Breisgau, Kiel, Tuebingen
- Életkor
- 18 év to 80 év
- People
- 150 worldwide
- Run by
- OncoZenge AB
See details and how to joinNCT07672236 · EU 2025-524386-24-00 - 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Frankfurt
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Berlin, Dresden, Heidelberg, Heilbronn, Leipzig, Mainz, Muenster
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - No phaseTaking peopleCisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer
- Where
- Nuremberg
- Életkor
- 18 év to 85 év
- People
- 55
- Run by
- Simon Jäger
See details and how to joinNCT06929468 - 2. fázisNot yet taking people in NémetországSafety and Efficacy of Ruxolitinib in Patients With HNSCC and High NLR Treated With Pembrolizumab - The Phase 2 InflammaSTOP Trial
- Where
- Cologne, Greifswald, Hagen, Hamburg, Würzburg
- Életkor
- 18 év and over
- People
- 66 worldwide
- Run by
- University Hospital, Basel, Switzerland
See details and how to joinNCT07840456 - 2. fázisNot yet taking people in NémetországA Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC
- Where
- Cologne, Giessen, Hamburg, Heidelberg, Kiel, Leipzig, Luebeck, Mannheim, Munich, Wuerzburg
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Bicara Therapeutics
See details and how to joinNCT07807163 · EU 2026-526741-10-00 - 3. fázisNot yet taking people in NémetországA Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
- Where
- Cologne, Leipzig, Münster
- Életkor
- 18 év and over
- People
- 260 worldwide
- Run by
- Corbus Pharmaceuticals Inc.
See details and how to joinNCT07768189 · EU 2026-527123-94-00 - 1/2. fázisTaking peopleThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Where
- Augsburg, Essen, Frankfurt am Main, Hamburg, Heidelberg
- Életkor
- 12 év and over
- People
- 300 worldwide
- Run by
- PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750 - 1. fázisTaking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Essen, Heidelberg, Herne, Jena, Nuertingen, Tuebingen
- Életkor
- 18 év and over
- People
- 1394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - 3. fázisTaking peopleA Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
- Where
- Berlin, Erlangen, Essen, Freiburg im Breisgau, Greifswald, Hamburg, Hanover, Leipzig, Lübeck, München, Rostock, Tübingen, Ulm, Würzburg
- Életkor
- 18 év to 130 év
- People
- 1145 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06129864 - No phaseTaking peopleTo Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.
- Where
- Essen
- Életkor
- 18 év and over
- People
- 850 worldwide
- Run by
- XEOS Medical
See details and how to joinNCT06970275 - No phaseTaking peopleORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Where
- Hamburg, Heilbronn, Munich
- Életkor
- 18 év and over
- People
- 2285 worldwide
- Run by
- Guardant Health, Inc.
See details and how to joinNCT05059444 - 2. fázisTaking peopleStudy of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Where
- Cologne, Frankfurt am Main, Gauting, Grosshansdorf, Hamburg, Heidelberg, Leipzig, Mainz, Muenster, Offenbach Am Main, Regensburg, Rheine
- Életkor
- 18 év to 64 év
- People
- 257 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06535607 · EU 2025-523947-36-00 - 3. fázisTaking peopleRe-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCC
- Where
- Berlin, Chemnitz, Darmstadt, Dresden, Erfurt, Erlangen, Frankfurt Am Main, Giessen, Hamburg, Hanover, Herne, Homburg, Kiel, Leipzig, Mainz, Muenster, Munich, Regensburg, Rostock, Straubing, Stuttgart, Tuebingen, Ulm
- Életkor
- 18 év and over
- People
- 214 worldwide
- Run by
- Universität des Saarlandes
See details and how to joinNCT07026474 · EU 2024-520264-33-00 - 1/2. fázisTaking peopleSafety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma
- Where
- Berlin, Cologne, Giessen, Goettingen, Hamburg
- Életkor
- 18 év and over
- People
- 110 worldwide
- Run by
- Nykode Therapeutics ASA
See details and how to joinNCT06016920 · EU 2022-503055-26-00 - 1/2. fázisTaking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Dresden, Essen, Frankfurt, Ulm, Würzburg
- Életkor
- 18 év and over
- People
- 1109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - No phaseTaking peopleApp-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tumors During and After Radio(Chemo)Therapy
- Where
- Erlangen
- Életkor
- 18 év and over
- People
- 148
- Run by
- University of Erlangen-Nürnberg Medical School
See details and how to joinNCT06367257 - No phaseTaking peopleImmune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel
- Where
- Erlangen
- Életkor
- 18 év and over
- People
- 250
- Run by
- University of Erlangen-Nürnberg Medical School
See details and how to joinNCT06947668 - 1. fázisTaking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Berlin
- Életkor
- 18 év and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00